DK119767B - Analogifremgangsmåde til fremstilling af terapeutisk virksomme estere eller farmaceutisk acceptable syreadditionssalte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af terapeutisk virksomme estere eller farmaceutisk acceptable syreadditionssalte deraf.

Info

Publication number
DK119767B
DK119767B DK124969AA DK124969A DK119767B DK 119767 B DK119767 B DK 119767B DK 124969A A DK124969A A DK 124969AA DK 124969 A DK124969 A DK 124969A DK 119767 B DK119767 B DK 119767B
Authority
DK
Denmark
Prior art keywords
preparation
pharmaceutically acceptable
acid addition
addition salts
acceptable acid
Prior art date
Application number
DK124969AA
Other languages
English (en)
Inventor
P Doyle
G Stacey
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of DK119767B publication Critical patent/DK119767B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK124969AA 1966-12-02 1969-03-06 Analogifremgangsmåde til fremstilling af terapeutisk virksomme estere eller farmaceutisk acceptable syreadditionssalte deraf. DK119767B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB54135/66A GB1147068A (en) 1966-12-02 1966-12-02 Phenyl-pyridine derivatives
US6140670A 1970-08-05 1970-08-05

Publications (1)

Publication Number Publication Date
DK119767B true DK119767B (da) 1971-02-22

Family

ID=26267415

Family Applications (4)

Application Number Title Priority Date Filing Date
DK604167AA DK119877B (da) 1966-12-02 1967-12-01 Analogifremgangsmåde til fremstilling af terapeutisk virksomme carboxylsyrer eller farmaceutisk acceptable salte heraf.
DK124969AA DK119767B (da) 1966-12-02 1969-03-06 Analogifremgangsmåde til fremstilling af terapeutisk virksomme estere eller farmaceutisk acceptable syreadditionssalte deraf.
DK125069AA DK119768B (da) 1966-12-02 1969-03-06 Analogifremgangsmåde til fremstilling af terapeutisk virksomme pyridinsubstituerede malonater eller farmaceutisk acceptable syreadditionssalte deraf.
DK125169AA DK119659B (da) 1966-12-02 1969-03-06 Analogifremgangsmåde til fremstilling af terapeutisk virksomme estere eller syreadditionssalte deraf.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK604167AA DK119877B (da) 1966-12-02 1967-12-01 Analogifremgangsmåde til fremstilling af terapeutisk virksomme carboxylsyrer eller farmaceutisk acceptable salte heraf.

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK125069AA DK119768B (da) 1966-12-02 1969-03-06 Analogifremgangsmåde til fremstilling af terapeutisk virksomme pyridinsubstituerede malonater eller farmaceutisk acceptable syreadditionssalte deraf.
DK125169AA DK119659B (da) 1966-12-02 1969-03-06 Analogifremgangsmåde til fremstilling af terapeutisk virksomme estere eller syreadditionssalte deraf.

Country Status (11)

Country Link
US (3) US3546237A (da)
BE (1) BE707445A (da)
CH (3) CH492712A (da)
DE (1) DE1695294A1 (da)
DK (4) DK119877B (da)
ES (1) ES347890A1 (da)
FI (1) FI50409C (da)
FR (2) FR1580824A (da)
GB (1) GB1147068A (da)
NL (1) NL6716375A (da)
SE (4) SE349572B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1217925A (en) * 1968-06-14 1971-01-06 Ici Ltd Process for manufacture of phenyl-heterocyclic-acetic acid derivatives
FR2248027B2 (da) * 1973-10-18 1977-09-09 Serdex
EP0067511A3 (en) * 1981-05-19 1983-04-06 Imperial Chemical Industries Plc Method of inducing tillering using pyridine derivatives, and some of the pyridines themselves, process for preparing them and agricultural compositions containing them
US4719303A (en) * 1983-11-21 1988-01-12 American Cyanamid Company Preparation of substituted and unsubstituted 2-[(1-carbamoyl-1,2-dimethylpropyl)-carbamoyl]-3-quinolinecarboxylic, nicotinic and benzoic acids
JPH0680041B2 (ja) * 1985-11-08 1994-10-12 サントリー株式会社 ２−ピリジル酢酸誘導体、その製法およびそれを含む医薬
US5521316A (en) * 1994-05-20 1996-05-28 Cytec Technology Corp. Chloroalkyl pyridinum hydrochloride compounds and processes for their preparation
CA2448198A1 (en) * 2001-05-22 2002-12-05 Neurogen Corporation 5-substituted-2-arylpyridines as crf1 modulators
US20100256147A1 (en) * 2007-04-13 2010-10-07 Hangauer Jr David G Biaryl acetamide derivatives as modulators of the kinase cascade for the treatment of hearing loss, osteoporosis and cell proliferation disorders
WO2009009041A2 (en) * 2007-07-06 2009-01-15 Kinex Pharmaceuticals, Llc Compositions and methods for modulating a kinase cascade
CN109999040A (zh) 2012-08-30 2019-07-12 阿西纳斯公司 蛋白质酪氨酸激酶调节剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3396224A (en) * 1965-09-09 1968-08-06 Lilly Co Eli Controlling phytopathogenic fungi on plants with 3-pyridyl methane derivatives
US3381015A (en) * 1965-12-30 1968-04-30 Merck & Co Inc Lower-cycloalkyl and lower-cycloalkenyl pyridineacetic acid and derivatives

Also Published As

Publication number Publication date
FR7540M (da) 1969-12-22
CH554340A (de) 1974-09-30
US3673198A (en) 1972-06-27
CH544090A (de) 1973-12-28
US3699227A (en) 1972-10-17
DK119877B (da) 1971-03-08
US3546237A (en) 1970-12-08
NL6716375A (da) 1968-06-04
SE349574B (da) 1972-10-02
FR1580824A (da) 1969-09-12
DE1695294A1 (de) 1972-01-20
BE707445A (da) 1968-06-04
SE349572B (da) 1972-10-02
GB1147068A (en) 1969-04-02
SE349573B (da) 1972-10-02
CH492712A (de) 1970-06-30
SE349575B (da) 1972-10-02
DK119768B (da) 1971-02-22
FI50409B (da) 1975-12-01
FI50409C (fi) 1976-03-10
ES347890A1 (es) 1969-02-16
DK119659B (da) 1971-02-08

Similar Documents

Publication Publication Date Title
DK117827B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme carboxylsyrederivater eller estere, amider eller salte deraf.
FI49497C (fi) Menetelmä terapeuttisesti vaikuttavien 1-fenoksi-2-3-alkyyliaminopropa anien valmistamiseksi.
DK133372B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive hydroxy-cyclohexyl-aminer eller syreadditionssalte deraf.
DK133669B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksome aminoestere af 4-pentynsyrer eller syreadditionssalte eller kvaternære forbindelser deraf.
DK114200B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme, basisk substituerede cycloalkenderivater eller syreadditionssalte deraf.
FI49720C (fi) Menetelmä terapeuttisesti vaikuttavien 2-metyyli-3-karbonihappoamidoki noksaliini-di-N-oksidien-(1,4) valmistamiseksi.
DK119767B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme estere eller farmaceutisk acceptable syreadditionssalte deraf.
DK118344B (da) Fremgangsmåde til fremstilling af et terapeutisk aktivt decapeptid eller salte heraf.
FI46501C (fi) Menetelmä terapeuttisesti aktiivisten, substituoitujen fenyylietikkaha ppoestereiden valmistamiseksi.
DK114207B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme phenylalaninderivater eller syreadditionssalte deraf.
FI49718C (fi) Menetelmä terapeuttisesti vaikuttavien 2-halogeenimetyyli-3-karbonihap poamidokinoksaliini-di-N-oksidien-(1,4) valmistamiseksi.
FI49032C (fi) Menetelmä terapeuttisesti aktiivisten 7-nitro-8-hydroksi-kinoliini-est erien valmistamiseksi.
FI48576C (fi) Menetelmä terapeuttisesti aktiivisten alfa-fluori-malonihappojohdannai sten valmistamiseksi.
DK115842B (da) Fremgangsmåde til fremstilling af terapeutisk aktive substituerede 4-aminobutynylsuccinimider eller 4-aminobutynylglutarimider eller syreadditionssalte deraf.
DK118767B (da) Fremgangsmåde til fremstilling af N-hydroxyimidothiocarboxylsyreestere.
FI47766C (fi) Menetelmä farmaseuttisesti vaikuttavien tropahappojen alkaloidiesterei den valmistamiseksi.
FI46955C (fi) Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-alempi-al kyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi
DK115260B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme amider af aliphatiske carboxylsyrer eller syreadditionssalte deraf.
DK115393B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme amider af aliphatiske carboxylsyrer eller syreadditionssalte deraf.
DK124551B (da) Analogifremgangsmåde til af terapeutisk virksomme phenthiazinderivater eller syreadditionssalte deraf.
FI48736C (fi) Menetelmä 2-bentsimidatsolikarbamiinihappoesterien valmistamiseksi.
DK115917B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive alkoxypyrimidineddikesyrederivater.
DK114832B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 3β-hydroxy-16α-alkyl-δ<4>-pregnenderivater eller estere deraf.
DK116217B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive pyrimidineddikesyreestere.
DK118716B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive 6α-methyl-16-methylen-Δ<4>-ostren-17β-oler eller estere deraf.